Primary advantages are scale procurement, broad manufacturing footprint near customers, and a more complete multi‑format portfolio post‑merger that deepens relationships with global CPG and healthcare clients. Healthcare and certain dispensing formats carry testing and regulatory qualification that raise switching costs relative to commodity films.
Efficient scale applies in some local markets where capacity additions would depress returns. These are durable but not indestructible advantages given intense competition, limited IP barriers and customer bargaining power. Morningstar categorizes Amcor as narrow moat on cost advantages, consistent with our view.
Key erosion risks include resin cost spikes outpacing pass‑through, sustainability regulation that shifts materials mix, and private‑label price pressure.







